Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Piclidenoson

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Can-Fite Starts Phase 3 Psoriasis Study of Piclidenoson with FDA
    Can-Fite Starts Phase 3 Psoriasis Study of Piclidenoson with FDA

    24 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/24/3047925/0/en/Can-Fite-Initiates-Pivotal-Phase-3-Psoriasis-Study-of-its-Oral-Drug-Piclidenoson-with-FDA-EMA-Approved-Protocol.html

    GLOBENEWSWIRE
    24 Mar 2025
    Share Share
    Can-Fite, Vetbiolix Accelerate Piclidenoson Develop in $3.8B Market
    Can-Fite, Vetbiolix Accelerate Piclidenoson Develop in $3.8B Market

    20 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/20/3046342/0/en/Can-Fite-Partner-Vetbiolix-Accelerate-Piclidenoson-Development-with-Advanced-Clinical-Trial-for-Canine-Osteoarthritis-in-a-3-8-Billion-Market.html

    GLOBENEWSWIRE
    20 Mar 2025
    Share Share
    Patient Improvement Reported With Namodenoson In Liver Cirrhosis
    Patient Improvement Reported With Namodenoson In Liver Cirrhosis

    01 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/01/2906564/0/en/Improvement-in-Patient-with-Decompensated-Liver-Cirrhosis-Upon-Treatment-with-Namodenoson.html

    GLOBENEWSWIRE
    01 Jul 2024
    Share Share
    Can-Fite Submitted to FDA a Pediatric Plan to Allow Registration of Piclidenoson
    Can-Fite Submitted to FDA a Pediatric Plan to Allow Registration of Piclidenoson

    18 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230818971170/en

    BUSINESSWIRE
    18 Aug 2023
    Share Share
    Can-Fite Receives USFDA’s Go Ahead for Piclidenoson Psoriasis Registration Plan
    Can-Fite Receives USFDA’s Go Ahead for Piclidenoson Psoriasis Registration Plan

    29 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230629172102/en

    BUSINESSWIRE
    29 Jun 2023
    Share Share
    Can-Fite to Conduct Meetings at the BIO-Europe Spring Conference with Companies
    Can-Fite to Conduct Meetings at the BIO-Europe Spring Conference with Companies

    16 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230316005101/en

    BUSINESSWIRE
    16 Mar 2023
    Share Share